Excelsior Medical Co., Ltd. (TPE:4104)
Taiwan · Delayed Price · Currency is TWD 81.70
+0.10 (0.12%)
At close: Dec 3, 2025
Excelsior Medical Market Cap
Excelsior Medical has a market cap or net worth of 14.02 billion as of December 3, 2025. Its market cap has decreased by -1.74% in one year.
Market Cap
14.02B
Enterprise Value
15.38B
Revenue
8.79B
Ranking
n/a
PE Ratio
17.47
Stock Price
81.70
Market Cap Chart
Since July 3, 2003, Excelsior Medical's market cap has increased from 2.50B to 14.02B, an increase of 460.93%. That is a compound annual growth rate of 7.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2025 | 14.00B | -0.37% |
| Dec 31, 2024 | 14.05B | 2.15% |
| Dec 29, 2023 | 13.76B | 37.31% |
| Dec 30, 2022 | 10.02B | 23.23% |
| Dec 30, 2021 | 8.13B | 2.67% |
| Dec 31, 2020 | 7.92B | 14.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 243.49B |
| PharmaEssentia | 190.47B |
| Lotus Pharmaceutical | 82.97B |
| Bora Pharmaceuticals Co., LTD. | 66.68B |
| Lin BioScience | 35.74B |
| Lumosa Therapeutics | 34.03B |
| Oneness Biotech | 32.72B |
| Center Laboratories | 28.52B |